Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children with Crohn's Disease.

Grossi V, Lerer T, Griffiths A, LeLeiko N, Cabrera J, Otley A, Rick J, Mack D, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Boyle B, Oliva-Hemker M, Keljo D, Pfefferkorn M, Faubion W, Kappelman MD, Sudel B, Markowitz J, Hyams JS.

Clin Gastroenterol Hepatol. 2015 Apr 21. pii: S1542-3565(15)00412-7. doi: 10.1016/j.cgh.2015.04.010. [Epub ahead of print]

PMID:
25911120
2.

Bridging the Gap Between Host Immune Response and Intestinal Dysbiosis in Inflammatory Bowel Disease: Does Immunoglobulin A Mark the Spot?

Shapiro JM, Cho JH, Sands BE, LeLeiko NS.

Clin Gastroenterol Hepatol. 2015 May;13(5):842-846. doi: 10.1016/j.cgh.2015.02.028. Epub 2015 Feb 25. Review.

PMID:
25725444
3.

CHD6 regulates the topological arrangement of the CFTR locus.

Sancho A, Li S, Paul T, Zhang F, Aguilo F, Vashisht A, Balasubramaniyan N, Leleiko NS, Suchy FJ, Wohlschlegel JA, Zhang W, Walsh MJ.

Hum Mol Genet. 2015 May 15;24(10):2724-32. doi: 10.1093/hmg/ddv032. Epub 2015 Jan 28.

4.

Testing for Clostridium difficile in patients newly diagnosed with inflammatory bowel disease in a community setting.

Krishnarao A, de Leon L, Bright R, Moniz H, Law M, Leleiko N, Sands BE, Merrick M, Shapiro J, Wallenstein S, Giacalone J, Shah SA.

Inflamm Bowel Dis. 2015 Mar;21(3):564-9. doi: 10.1097/MIB.0000000000000309.

PMID:
25581825
5.

Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.

Sunseri W, Hyams JS, Lerer T, Mack DR, Griffiths AM, Otley AR, Rosh JR, Carvalho R, Grossman AB, Cabrera J, Pfefferkorn MD, Rick J, Leleiko NS, Hitch MC, Oliva-Hemker M, Saeed SA, Kappelman M, Markowitz J, Keljo DJ; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

Inflamm Bowel Dis. 2014 Aug;20(8):1341-5. doi: 10.1097/MIB.0000000000000102.

PMID:
24983976
6.

Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease.

Goyal A, Hyams JS, Lerer T, Leleiko NS, Otley AR, Griffiths AM, Rosh JR, Cabrera JM, Oliva-Hemker MM, Mack DR, Rick JN, Pfefferkorn MD, Carvalho R, Grossman AB, Hitch MC, Sudel B, Kappelman MD, Saeed SA, Faubion WA, Schaefer ME, Markowitz JF, Keljo DJ; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):321-3. doi: 10.1097/MPG.0000000000000409.

PMID:
24796799
7.

Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity.

Cohen BL, Zoëga H, Shah SA, Leleiko N, Lidofsky S, Bright R, Flowers N, Law M, Moniz H, Merrick M, Sands BE.

Aliment Pharmacol Ther. 2014 Apr;39(8):811-22. doi: 10.1111/apt.12659. Epub 2014 Feb 20.

8.

Depressive symptoms in youth with inflammatory bowel disease compared with a community sample.

Reed-Knight B, Lobato D, Hagin S, McQuaid EL, Seifer R, Kopel SJ, Boergers J, Nassau JH, Suorsa K, Bancroft B, Shapiro J, Leleiko NS.

Inflamm Bowel Dis. 2014 Apr;20(4):614-21. doi: 10.1097/01.MIB.0000442678.62674.b7.

9.

Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV Jr, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE.

Inflamm Bowel Dis. 2014 Feb;20(2):398-415. doi: 10.1097/01.MIB.0000435441.30107.8b. Review.

PMID:
24280882
10.

Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.

Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS; PRO-KIIDS Research Group.

Gastroenterology. 2014 Feb;146(2):383-91. doi: 10.1053/j.gastro.2013.10.027. Epub 2013 Oct 23.

PMID:
24162032
11.

6-Thioguanine levels in pediatric IBD patients: adherence is more important than dose.

LeLeiko NS, Lobato D, Hagin S, Hayes C, McQuaid EL, Seifer R, Kopel SJ, Boergers J, Nassau J, Suorsa K, Shapiro J, Bancroft B.

Inflamm Bowel Dis. 2013 Nov;19(12):2652-8. doi: 10.1097/01.MIB.0000436960.00405.56.

PMID:
24105391
12.

Rates and predictors of oral medication adherence in pediatric patients with IBD.

LeLeiko NS, Lobato D, Hagin S, McQuaid E, Seifer R, Kopel SJ, Boergers J, Nassau J, Suorsa K, Shapiro J, Bancroft B.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):832-9. doi: 10.1097/MIB.0b013e3182802b57.

PMID:
23446336
13.

Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.

Wine E, Mack DR, Hyams J, Otley AR, Markowitz J, Crandall WV, Leleiko N, Muise AM, Griffiths AM, Turner D.

J Crohns Colitis. 2013 Dec 1;7(11):916-22. doi: 10.1016/j.crohns.2012.12.012. Epub 2013 Jan 20.

14.

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.

Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C.

Genome Biol. 2012 Apr 16;13(9):R79. doi: 10.1186/gb-2012-13-9-r79.

15.

Rectal suction biopsy to exclude the diagnosis of Hirschsprung disease.

Hayes CE, Kawatu D, Mangray S, LeLeiko NS.

J Pediatr Gastroenterol Nutr. 2012 Sep;55(3):268-71. doi: 10.1097/MPG.0b013e31824c0acc.

PMID:
22922333
16.

Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis.

Zeisler B, Lerer T, Markowitz J, Mack D, Griffiths A, Bousvaros A, Keljo D, Rosh J, Evans J, Kappelman M, Otley A, Kay M, Grossman A, Saeed S, Carvalho R, Oliva-Hemker M, Faubion W, Sudel B, Pfefferkorn M, Ashai-Khan F, Leleiko N, Hyams J; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2013 Jan;56(1):12-8. doi: 10.1097/MPG.0b013e31826ac41a.

PMID:
22847466
17.

Evaluation of possible inflammatory bowel disease: a survey of Rhode Island physicians.

Saha S, Lam M, Roberson E, Shah S, LeLeiko NS, Lidofsky S, Bright R, Flowers N, Merrick M, Sands BE.

Med Health R I. 2012 Jan;95(1):4-8.

18.

Budesonide use in pediatric Crohn disease.

Otley A, LeLeiko N, Langton C, Lerer T, Mack D, Evans J, Pfefferkorn M, Carvalho R, Rosh J, Griffiths A, Oliva-Hemker M, Kay M, Bousvaros A, Stephens M, Samson C, Grossman A, Keljo D, Markowitz J, Hyams J; Pediatric IBD Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):200-4. doi: 10.1097/MPG.0b013e31824a09c2.

PMID:
22258289
19.

Feasibility of using MR enterography for the assessment of terminal ileitis and inflammatory activity in children with Crohn disease.

Silverstein J, Grand D, Kawatu D, Shah SA, Steinkeler J, LeLeiko N.

J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):173-7. doi: 10.1097/MPG.0b013e318249595d.

PMID:
22241511
20.

Alterations in the gut microbiome of children with severe ulcerative colitis.

Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J, Leleiko N, Kenche H, Stolfi A, Wine E.

Inflamm Bowel Dis. 2012 Oct;18(10):1799-808. doi: 10.1002/ibd.22860. Epub 2011 Dec 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk